| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6015647 | Epilepsy Research | 2015 | 8 Pages |
Abstract
Neurodevelopmental outcome was overall poor in patients with IS and has not changed since the publication of first guideline on IS. Although cryptogenic IS has better prognosis than symptomatic IS, the outcome for cryptogenic IS remained poor. There was heterogeneity in neurodevelopmental outcome ascertainment methods, highlighting the need for a more standardized and comprehensive assessment of cognitive, behavioural, emotional and functional outcomes.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Elysa Widjaja, Cristina Go, Blathnaid McCoy, O. Carter Snead,